hydroxyproline has been researched along with exenatide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, T; Le, Y; Wang, K; Wei, R; Wei, T; Xiao, W; Yang, J; Yang, K | 1 |
1 other study(ies) available for hydroxyproline and exenatide
| Article | Year |
|---|---|
Non-targeted metabolomic analysis predicts the therapeutic effects of exenatide on endothelial injury in patients with type 2 diabetes.
Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Endothelium, Vascular; Exenatide; Glycated Hemoglobin; Humans; Hydroxyproline; Hypoglycemic Agents; Metabolomics | 2021 |